Term ends May 29, 2039 · Medium confidence
20-year base term ends May 5, 2037
Why Medium: A parent in the chain could not be resolved.
Held by Vantive US Healthcare LLC
Filed Nov 1, 2019 as application 16/610,384 · Granted Aug 8, 2023
Base term plus 754 days of patent term adjustment (USPTO delay)
Today
2017
2039
Clock starts
May 5, 2017
May 5, 2017
Term ends
May 29, 2039
May 29, 2039
Granted
Aug 8, 2023
Aug 8, 2023
base term
patent term adjustment
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
754
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 754 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 5, 2017, when applications 15/588,454 and PCT/US2017/031405, the earliest non-provisional applications in its chain, were filed (this one was filed Nov 1, 2019); a parent in its chain could not be resolved (the next row) | May 5, 2037 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | +754 days, USPTO patent term adjustment record | May 29, 2039 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | May 29, 2039 | Medium confidence |
Partial family
| US 10,828,412 | In force Oct 2038 | Oct 2038 |
| Application PCT/US2017/031405 | PCT application no patent term | no patent term |
| Application PCT/EP2017/078347 | PCT application no patent term | no patent term |
| US 11,718,546 | this patent May 2039 | May 2039 |
| US 11,939,251 | In force Nov 2038 | Nov 2038 |
| US 12,790,246 | In force Jan 2038 | Jan 2038 |
| Application 18/612,526 | Pending not computed | not computed |
Partial: 1 of the 7 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 24, 2020 Reel 53023, frame 939 | Wieslander, Anders; Jansson, Olof; Wictor, Per-ola | Gambro Lundia AB | Assignment of Assignor's Interest |
| Jun 24, 2020 Reel 53027, frame 461 | Wellings, Anders | Baxter International Inc.; Baxter Healthcare S.A. | Assignment of Assignor's Interest |
| Jun 24, 2020 Reel 53030, frame 223 | Jeppsson, Helena | Gambro Lundia AB | Assignment of Assignor's Interest |
| Jun 24, 2020 reel/frame not recorded | Wellings, Anders | Baxter International Inc. | Assignment of Assignor's Interest |
| Jun 24, 2020 reel/frame not recorded | Wellings, Anders | Baxter Healthcare S.A. | Assignment of Assignor's Interest |
| Jun 25, 2020 Reel 53037, frame 115 | Gambro Lundia AB | Baxter International Inc.; Baxter Healthcare S.A. | Assignment of Assignor's Interest |
| Jun 25, 2020 reel/frame not recorded | Gambro Lundia AB | Baxter International Inc. | Assignment of Assignor's Interest |
| Jun 25, 2020 reel/frame not recorded | Gambro Lundia AB | Baxter Healthcare S.A. | Assignment of Assignor's Interest |
| Jan 31, 2025 Reel 70076, frame 701 | Vantive US Healthcare LLC; Gambro Renal Products, Inc. | Ares Capital Corporation | Security Interest |
| Oct 31, 2025 Reel 73413, frame 1 | Baxter International Inc. | Vantive US Healthcare LLC | Assignment of Assignor's Interest |
| Oct 31, 2025 Reel 73438, frame 790 | Baxter Healthcare S.A. | Vantive Health GmbH | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
May 2039
Term ends May 29, 2039. Maintenance fees still fall due before then
Note
The 754 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
0
later US patents cite this one
That is below the median of utility patents granted in 2023 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.